Pura Vida Investments, LLC Arcutis Biotherapeutics, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$16.33 - $22.2 $1.46 Million - $1.98 Million	-89,363 Reduced 47.19%	100,000 $2.13 Million
Q1 2022 May 16, 2022	BUY	$14.38 - $22.79 $729,066 - $1.16 Million	50,700 Added 36.56%	189,363 $3.65 Million
Q4 2021 Feb 14, 2022	BUY	$14.98 - $25.5 $394,558 - $671,644	26,339 Added 23.45%	138,663 $2.88 Million
Q3 2021 Nov 15, 2021	SELL	$19.28 - $27.1 $33,489 - $47,072	-1,737 Reduced 1.52%	112,324 $2.68 Million
Q2 2021 Aug 16, 2021	SELL	$24.42 - $34.75 $773,698 - $1.1 Million	-31,683 Reduced 21.74%	114,061 $3.11 Million

Q1 2021 May 12, 2021	BUY	$24.47 - $36.98 $3.57 Million - $5.39 Million	145,744 New	145,744 $4.22 Million

172

126M

498K

1.64M

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $560M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.